Apriem Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-3,275
| Closed | -$213K | – | 135 |
|
|
2019
Q1 | $213K | Sell |
3,275
-162
| -5% | -$10.5K | 0.06% | 119 |
|
|
2018
Q4 | $215K | Sell |
3,437
-800
| -19% | -$50K | 0.08% | 113 |
|
|
2018
Q3 | $327K | Buy |
4,237
+150
| +4% | +$11.6K | 0.07% | 101 |
|
|
2018
Q2 | $290K | Sell |
4,087
-200
| -5% | -$14.2K | 0.07% | 103 |
|
|
2018
Q1 | $323K | Buy |
4,287
+800
| +23% | +$60.3K | 0.08% | 92 |
|
|
2017
Q4 | $250K | Sell |
3,487
-738
| -17% | -$52.9K | 0.06% | 111 |
|
|
2017
Q3 | $342K | Buy |
4,225
+446
| +12% | +$36.1K | 0.09% | 95 |
|
|
2017
Q2 | $267K | Sell |
3,779
-591
| -14% | -$41.8K | 0.07% | 107 |
|
|
2017
Q1 | $297K | Sell |
4,370
-700
| -14% | -$47.6K | 0.08% | 98 |
|
|
2016
Q4 | $363K | Sell |
5,070
-23,385
| -82% | -$1.67M | 0.11% | 88 |
|
|
2016
Q3 | $2.25M | Buy |
28,455
+499
| +2% | +$39.5K | 0.67% | 39 |
|
|
2016
Q2 | $2.33M | Buy |
27,956
+1,368
| +5% | +$114K | 0.76% | 34 |
|
|
2016
Q1 | $2.44M | Sell |
26,588
-772
| -3% | -$70.9K | 0.96% | 29 |
|
|
2015
Q4 | $2.77M | Sell |
27,360
-491
| -2% | -$49.7K | 0.99% | 33 |
|
|
2015
Q3 | $2.74M | Buy |
27,851
+1,171
| +4% | +$115K | 1.01% | 30 |
|
|
2015
Q2 | $3.12M | Sell |
26,680
-3,258
| -11% | -$381K | 1.07% | 31 |
|
|
2015
Q1 | $2.94M | Buy |
29,938
+3,553
| +13% | +$349K | 1.02% | 34 |
|
|
2014
Q4 | $2.49M | Buy |
26,385
+9,205
| +54% | +$868K | 0.92% | 39 |
|
|
2014
Q3 | $1.83M | Sell |
17,180
-550
| -3% | -$58.6K | 0.7% | 50 |
|
|
2014
Q2 | $1.47M | Buy |
17,730
+2,100
| +13% | +$174K | 0.56% | 53 |
|
|
2014
Q1 | $1.11M | Buy |
15,630
+15,330
| +5,110% | +$1.09M | 0.42% | 59 |
|
|
2013
Q4 | $23K | Buy |
+300
| New | +$23K | 0.01% | 277 |
|